Can angiofibroma (a type of skin tumor) or sebaceous hyperplasia (a type of skin condition) be treated with cryotherapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Angiofibroma and Sebaceous Hyperplasia with Cryotherapy

Cryotherapy is an effective treatment option for sebaceous hyperplasia but has insufficient evidence to support its use for angiofibroma.

Sebaceous Hyperplasia Treatment

Efficacy of Cryotherapy for Sebaceous Hyperplasia

  • Cryotherapy is highly effective for treating sebaceous hyperplasia with excellent response rates of 65.9% after 6 treatment cycles 1
  • Recent randomized clinical trial evidence shows that sebaceous hyperplasia responds better to cryotherapy than electrosurgery 2
  • Treatment typically requires 1-2 sessions for resolution, with multiple sessions (up to 6) at 2-week intervals providing optimal results 1

Cryotherapy Technique for Sebaceous Hyperplasia

  • Use liquid nitrogen spray technique with a controlled freeze-thaw cycle
  • Target each lesion individually, ensuring complete freezing of the lesion
  • For optimal results, consider multiple treatment sessions spaced 2 weeks apart 1
  • Lesions ranging from 2-9mm on the forehead, cheeks, and chin can be effectively treated 1

Factors Affecting Treatment Success

  • Age and sex are independent predictors of excellent response, with better outcomes in:
    • Males (71.4% excellent response vs 61.8% in females)
    • Patients older than 55 years (70.4% excellent response vs 61.8% in younger patients) 1

Side Effects and Complications

  • Temporary hyperpigmentation (0.96% of lesions) 1
  • Hypopigmentation and depigmentation (3.1% and 6.3% of cases, respectively) 2
  • Low risk of scarring when properly performed
  • Recurrence rates are minimal with proper technique 1

Angiofibroma Treatment

Evidence for Angiofibroma Treatment

  • Current guidelines from the British Association of Dermatologists (2019) state there is insufficient evidence to support any recommendation for angiofibroma treatment with photodynamic therapy 3
  • This lack of evidence extends to cryotherapy as well, with no high-quality studies specifically evaluating cryotherapy for angiofibromas

Alternative Treatment Options for Angiofibroma

  • Surgical excision is typically the first-line treatment for isolated angiofibromas
  • For multiple lesions, laser therapy may be more appropriate than cryotherapy
  • Topical rapamycin (sirolimus) has shown promise in recent studies, particularly for facial angiofibromas associated with tuberous sclerosis complex

Treatment Selection Algorithm

  1. For Sebaceous Hyperplasia:

    • First-line: Cryotherapy with liquid nitrogen (6 sessions at 2-week intervals)
    • Second-line: Electrosurgery if cryotherapy fails or is contraindicated
    • Monitor for hyperpigmentation or hypopigmentation
  2. For Angiofibroma:

    • First-line: Surgical excision for isolated lesions
    • For multiple lesions: Consider laser therapy or topical rapamycin
    • Cryotherapy should not be first-line due to insufficient evidence

Important Considerations and Precautions

  • Patient selection: Cryotherapy is most effective for sebaceous hyperplasia in older males (>55 years) 1
  • Diagnostic certainty: Ensure accurate diagnosis before treatment; worsening after cryotherapy may suggest malignancy requiring biopsy 4
  • Cosmetic outcomes: Cryotherapy generally provides good cosmetic results for sebaceous hyperplasia with minimal risk of scarring 1
  • Follow-up: Schedule follow-up at 3-4 months to assess for recurrence and treatment success

In conclusion, while cryotherapy represents an excellent, evidence-based treatment option for sebaceous hyperplasia with high success rates and minimal complications, it cannot be recommended as a first-line treatment for angiofibromas due to insufficient supporting evidence.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.